Albertsons Companies Reports Q4 Earnings with Mixed Results
Albertsons Companies reported Q4 identical-store sales up 0.7% and adjusted EBITDA of $903 million, but faced pharmacy-related headwinds. The company also announced a $774 million opioid settlement and increased shareholder returns with a 13% dividend hike and a $2 billion share buyback authorization.
Tickers: $ACI
Topics: Dividend Increase Earnings EBITDA Performance Opioid Settlement Pharmacy Headwinds Share Buybacks